通过核糖体剖析揭示的心脏缩中保存的翻译控制
Bao-Sen Wang1,2,3,4, Jian Lyu3,4,5, Hong-Chao Zhan3
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Sheng li xue bao : [Acta physiologica Sinica]
|October 31, 2025
概括
病理性心脏缩包括蛋白质合成的增加. 这项研究揭示了新的转化调节机制,并确定了治疗心力衰竭的保存目标.
科学领域:
- 心血管生物学 心血管生物学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 病理性心脏缩的特点是过度的蛋白质合成,但压力下的转化调节尚不清楚.
- 了解翻译控制对于开发心脏病治疗方法至关重要.
研究的目的:
- 在小鼠模型中研究心脏缩的转化规则,由心经狭窄 (TAC) 引起的心脏缩.
- 为了比较小鼠模型中的转化模式与人类扩张性心肌病 (DCM).
- 为了确定潜在的治疗干预的保存转化目标.
主要方法:
- 在小鼠中通过心经狭窄 (TAC) 诱导心脏缩.
- 使用普罗米辛纳入试验评估蛋白质合成速率.
- 利用RNA测序 (RNA-seq) 和核糖体分析分析基因表达和翻译效率 (TE).
- 结果与人类DCM患者的翻译数据进行了比较.
主要成果:
- 在小鼠中,TAC显著增加了心脏重量和心脏功能下降.
- 在TAC诱导的缩中,蛋白质合成率升高.
- RNA-seq和核糖体分析发现TE的广泛变化,其中1495个基因显示TE增强,933个基因显示TE抑制.
- 对人类DCM的分析揭示了转化水平上的差异性基因表达.
- 在小鼠和人类模型之间确定了93个具有改变TE的保存基因,这些基因与心肌功能,信号传递和新陈代谢有关.
结论:
- 新的翻译调节机制参与了病理性心脏缩.
- 确定了保存的转化标,特别是cGMP-PKG信号传递和脂肪酸代谢中的标.
- 这些发现为心脏缩和心力衰竭提供了潜在的治疗点.
相关概念视频
Translational Regulation
497
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
497
Ribosome Profiling
4.0K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.0K
Regulation of Expression at Multiple Steps
1.3K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Regulation of Expression Occurs at Multiple Steps
25.6K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
25.6K
Translation
17.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354


